List of Figures:

Figure 4-1: Global – Major Venture Capitalist Investments in Gene Therapy Product Development (Billion US$), 1999 to 2015
Figure 5-1: Global - Number of Approved Gene Therapy Clinical Trials (2005-July 2015)
Figure 5-2: Global - Geographical Distribution of Gene Therapy Clinical Trials by Continents (%)
Figure 5-3: Global - Geographical Distribution of Gene Therapy Clinical Trials by Countries (%)
Figure 5-4: Global - Gene Therapy Clinical Trials by Indication (%)
Figure 5-5: Global - Gene Therapy Clinical Trials by Types of Gene Transferred (%)
Figure 5-6: Global - Gene Therapy Clinical Trials by Vectors (%)
Figure 5-7: Global - Gene Therapy Clinical Trials by Phase (%)
Figure 6-1: US - Number of New Cell Therapy and Gene Therapy Products Submission to FDA (2003-2010)
Figure 6-2: Japan - Evaluation System of Gene Therapy Clinical Trial
Figure 7-1: Global - Neovasculgen Sales (Million US$), 2013 & 2014
Figure 8-1: Global - Gene Therapy Market (Million US$), 2014, 2015 & 2020
Figure 9-1: Global - Gene Therapy Market by Application (%), 2015
Figure 9-2: Global - Gene Therapy Market by Application (%), 2020
Figure 9-3: Global - Oncology Gene Therapy Clinical Trials by Vectors (%)
Figure 9-4: Global - Oncology Gene Therapy Clinical Trials by Phase (%)
Figure 9-5: Global - Oncology Gene Therapy Clinical Trials by Type (%)
Figure 9-6: Global - Oncology Gene Therapy Market (Million US$), 2014, 2015 & 2020
Figure 9-7: Global - Oncology Gene Therapy Market by Geography (%), 2015
Figure 9-8: Global – Key Cardiovascular Diseases Gene Therapy Ongoing Clinical Trials
Figure 9-9: Global - Cardiovascular Disease Gene Therapy Clinical Trials by Vectors (%)
Figure 9-10: Global - Cardiovascular Disease Gene Therapy Clinical Trials by Phase (%)
Figure 9-11: Global - Cardiovascular Disease Gene Therapy Clinical Trials by Type (%)
Figure 9-12: Global - Cardiovascular Disease Gene Therapy Market (Million US$), 2014, 2015 & 2020
Figure 9-13: Global - Cardiovascular Disease Gene Therapy Market by Geography (%), 2015
Figure 9-14: Global - Infectious Disease Gene Therapy Clinical Trials by Vectors (%)
Figure 9-15: Global - Infectious Disease Gene Therapy Clinical Trials by Phase (%)
Figure 9-16: Global - Infectious Disease Gene Therapy Clinical Trials by Type (%)
Figure 9-17: Global - Infectious Disease Gene Therapy Market (Million US$), 2014, 2015 & 2020
Figure 9-18: Global - Infectious Disease Gene Therapy Market by Geography (%), 2015
Figure 9-19: Global - Neurological Diseases Gene Therapy Clinical Trials by Vector (%)
Figure 9-20: Global - Neurological Diseases Gene Therapy Clinical Trials by Phase (%)
Figure 9-21: Global - Neurological Diseases Gene Therapy Clinical Trials by Type (%)
Figure 9-22: Global - Neurological Disease Gene Therapy Market (Million US$), 2014, 2015 & 2020
Figure 9-23: Global - Neurological Disease Gene Therapy Market by Geography (%), 2015
Figure 9-24: Global - Genetic Disease Gene Therapy Clinical Trials by Vector (%)
Figure 9-25: Global - Genetic Disease Gene Therapy Clinical Trials by Phase (%)
Figure 9-26: Global - Genetic Disease Gene Therapy Clinical Trials by Type (%)
Figure 9-27: Global - Genetic Disease Gene Therapy Market (Million US$), 2014, 2015 & 2020
Figure 9-28: Global - Genetic Disease Gene Therapy Market, by Geography (%), 2015
Figure 9-29: Global - Other Disease Gene Therapy Clinical Trials by Type (%)
Figure 9-30: Global - Other Disease Gene Therapy Market (Million US$), 2014, 2015 & 2020
Figure 9-31: Global - Other Disease Gene Therapy Market by Geography (%), 2015
Figure 10-1: Global - Gene Therapy Market by Geography (%), 2015
Figure 10-2: North America - Gene Therapy Market (Million US$), 2014, 2015 & 2020
Figure 10-3: Europe - Gene Therapy Market (Million US$), 2014, 2015 & 2020
Figure 10-4: Asia - Gene Therapy Market (Million US$), 2014, 2015 & 2020
Figure 10-5: Asia - Number of Gene Therapy Laboratories by Major Asian Countries (2014)
Figure 10-6: India - Number of Gene Therapy Laboratories (2000, 2010 & 2013)
Figure 10-7: Rest of the World - Gene Therapy Market (Million US$), 2014, 2015 & 2020
Figure 11-1: Key Growth Strategies Adopted by Key Players (2013 to 2015)
Figure 11-2: Key Players Focusing on Strategic Collaborations (2013 to 2015)
Figure 11-3: Key Players Focusing on Strategic Acquisitions (2013 to 2015)
Figure 11-4: Key Players Focusing on Funding & Investments (2013 to 2015)
Figure 11-5: Companies Progress in Gene Therapy till 2015

List of Tables:

Table 4-1: US - Gene Therapies under Development
Table 4-2: Europe - Gene Therapies under Development
Table 4-3: Gene Therapy Companies Funded by Venture Capital Firms
Table 4-4: Current Status of Clinical Trials for Hemophilia
Table 5-1: Human Gene Transfer Trials Approved by Condition
Table 5-2: Global - Key Gene Therapy Ongoing Clinical Trials
Table 6-1: China - Key Players and their Products in Gene Therapy
Table 9-1: Global - Key Oncology Gene Therapy Ongoing Clinical Trials
Table 9-2: Global - Oncology Incidence by Geography (‘000), 2015 & 2020
Table 9-3: Global - Key Infectious Disease Gene Therapy Ongoing Clinical Trials
Table 9-4: Global - HIV Prevalence & Incidence by Geography (‘000), 2014
Table 9-5: Global - Key Neurological Disease Gene Therapy Ongoing Clinical Trials
Table 9-6: Global - Parkinson Disease Prevalence by Geography (Million), 2010
Table 9-7: Global - Key Genetic Disease Gene Therapy Ongoing Clinical Trials
Table 9-8: Global - Hemophilia Prevalence by Geography, 2010 & 2013
Table 9-9: Global - Key Other Disease Gene Therapy Ongoing Clinical Trials
Table 12-1: Spark Therapeutics LLC - Clinical Pipeline in Gene Therapy
Table 12-2: ViroMed Co. Ltd. - Clinical Pipeline in Gene Therapy
Table 12-3: Advantagene Inc. - Clinical Pipeline in Gene Therapy
Table 12-4: Bluebird Bio - Clinical Pipeline in Gene Therapy
Table 12-5: Sanofi - Clinical Pipeline in Gene Therapy
Table 12-6: Vical Inc. - Clinical Pipeline in Gene Therapy
Table 12-7: Oxford Biomedica Plc - Clinical Pipeline in Gene Therapy
Table 12-8: Genethon - Clinical Pipeline in Gene Therapy
Table 12-9: UniQure N.V. - Clinical Pipeline in Gene Therapy
Table 12-10: Human Stem Cells Institute - Clinical Pipeline in Gene Therapy
Table 12-11: Shanghai Sunway Biotech Co. Ltd. - Clinical Pipeline in Gene Therapy
Table 12-12: Sibiono GeneTech Co. Ltd. - Clinical Pipeline in Gene Therapy